丁酸盐通过调节胆汁酸代谢来保护人免受困难菌感染
Siqi Wang1,2, Leyang Xiang3, Fang Li2,4
1Department of Gastroenterology, The First Affiliated of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
Microbiology spectrum
|June 23, 2023
概括
短链脂肪酸酸在治疗困难菌感染 (CDI) 中表现有前途,通过恢复胆酸代谢和激活farnesoid X受体 (FXR) 来恢复胆酸代谢. 这项研究强调了酸盐.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 困难菌感染 (CDI) 是医院获得感染的重要原因,在抗生素治疗后的复发率很高.
- 目前对CDI的治疗方法有限,需要开发新的治疗策略.
- 短链脂肪酸 (SCFA) 酸以其提供能量,抗炎性质和维持肠道屏障功能的作用而闻名,但其针对CDI的具体机制尚不清楚.
研究的目的:
- 研究丁酸盐在治疗困难菌感染 (CDI) 中的治疗潜力和潜在机制.
- 探索丁酸盐在调节胆酸代谢中的作用及其与Farnesoid X受体 (FXR) 的相互作用在CDI的背景下.
主要方法:
- 一个Clostridium difficile感染 (CDI) 鼠标模型被用于评估丁酸盐治疗的影响.
- 便样本分析了短链脂肪酸 (SCFA) 和胆汁酸 (BA) 的水平.
- 该研究检查了丁酸盐对胆盐酸酶 (BSH) 菌群,Farnesoid X受体 (FXR) 激活和肠道屏障功能的影响.
主要成果:
- 丁酸盐显著抑制了小鼠的CDI发育,与胆酸代谢的调节相关.
- 与健康对照组相比,患有CDI的患者表现出失调的便胆酸概况和较低的SCFA水平.
- 丁酸盐治疗增强了肠道屏障保护,减少了炎症,并调节了胆酸代谢,包括BSH菌群和FXR激活.
结论:
- 丁酸盐通过增强屏障功能,减少炎症,以及通过通过FXR激活调节胆酸代谢,在CDI中发挥保护作用.
- 当施用BSH或FXR抑制剂时,在CDI中丁酸盐的治疗效果会减弱,这凸显了这种途径的重要性.
- 丁酸盐代表了一种有前途的新型治疗方法,用于管理Clostridium difficile感染,可能为传统抗生素提供一种替代方案.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
230
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
230
Chronic Bowel Disorders: Introduction
490
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
490
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
360
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
360
Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179
Inflammatory Bowel Disease IV: Pharmacological Management
155
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
155
Drugs for Treatment of Diarrhea-Predominant IBS
218
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
218


